RaySearch Laboratories AB Stock

Equities

RAY B

SE0000135485

Advanced Medical Equipment & Technology

Real-time Estimate Cboe Europe 09:30:00 2024-06-10 am EDT 5-day change 1st Jan Change
147.4 SEK 0.00% Intraday chart for RaySearch Laboratories AB -0.27% +63.01%
Sales 2024 * 1.14B 108M Sales 2025 * 1.26B 119M Capitalization 5.05B 479M
Net income 2024 * 127M 12.03M Net income 2025 * 169M 16.01M EV / Sales 2024 * 4.52 x
Net Debt 2024 * 82.48M 7.82M Net cash position 2025 * 74.26M 7.04M EV / Sales 2025 * 3.95 x
P/E ratio 2024 *
39.9 x
P/E ratio 2025 *
29.9 x
Employees 398
Yield 2024 *
1.02%
Yield 2025 *
1.02%
Free-Float 71.84%
More Fundamentals * Assessed data
Dynamic Chart
1 week-0.27%
Current month-0.27%
1 month+11.01%
3 months+38.87%
6 months+59.48%
Current year+63.01%
More quotes
1 week
142.40
Extreme 142.4
149.00
1 month
122.60
Extreme 122.6
155.00
Current year
84.10
Extreme 84.1
155.00
1 year
55.60
Extreme 55.6
155.00
3 years
40.00
Extreme 40
155.00
5 years
40.00
Extreme 40
193.00
10 years
36.90
Extreme 36.9
274.50
More quotes
Managers TitleAgeSince
Founder 55 99-12-31
Director of Finance/CFO 55 23-07-06
Chief Tech/Sci/R&D Officer 51 00-12-31
Members of the board TitleAgeSince
Founder 79 99-12-31
Founder 55 99-12-31
Chairman 86 04-04-30
More insiders
Date Price Change Volume
24-06-10 147.2 -0.14% 9 846
24-06-07 147.4 +1.94% 43,667
24-06-05 144.6 -1.23% 34,680
24-06-04 146.4 -0.81% 41,681
24-06-03 147.6 0.00% 94,422

Delayed Quote Nasdaq Stockholm, June 10, 2024 at 09:14 am EDT

More quotes
RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
147.4 SEK
Average target price
135 SEK
Spread / Average Target
-8.41%
Consensus

Annual profits - Rate of surprise